CAH vs LNAI · P/E 35, rev $254.25B vs rev $20.9K
Cardinal Health Inc (CAH) versus Lunai Bioworks Inc. (LNAI) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Lunai Bioworks Inc. (LNAI) is a biotechnology company listed on NASDAQ.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported LNAI revenue for 2026-03-31 was $20.9K. Net income was -$1.6M. LNAI currently screens at market cap $12.4M.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. LNAI currently screens at market cap $12.4M.
Not investment advice. Open the CAH and LNAI stock pages for the full models.
Not investment advice.